1. 583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells. (10th December 2020) Authors: Gauthier, Kelsey Sivick; Piovesan, Dana; Lawson, Kenneth; Cho, Soonweng; Udyavar, Akshata; Chan, Jean; Chen, Ada; Au, Jennie; Meleza, Cesar; Zhao, Xiaoning; Tran, Anh; Drew, Samuel; Gal, Balint; Rosen, Brandon; Leleti, Manmohan; Ginn, Elaine; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells. (9th November 2020) Authors: Gauthier, Kelsey Sivick; Piovesan, Dana; Lawson, Kenneth; Cho, Soonweng; Udyavar, Akshata; Chan, Jean; Chen, Ada; Au, Jennie; Meleza, Cesar; Zhao, Xiaoning; Tran, Anh; Drew, Samuel; Gal, Balint; Rosen, Brandon; Leleti, Manmohan; Ginn, Elaine; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗